Impact of 18F NaF PET in Patients with Known Prostate Cancer
B.E. Hillner, B.A. Siegel, L. Hanna, F Duan, AF Shields, R. Coleman | 27-02-2014
The NOPR developed a 18F NaF PET registry based on prior 18F FDG PET registries. 72% of all men with prostate cancer are represented. 18F NaF PET has a high overall impact, due to its success of replacing the intended use of other imaging modalities.